B · Normal
[Deputy Director of the State Food and Drug Administration Yang Sheng investigated the drug innovation and R&D work in the Greater Bay Area in Guangdong] October 30th. Recently, Yang Sheng, a member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, led a team to Guangdong to investigate some drug research and development enterprises and the Greater Bay Area Drug Center and the Greater Bay Area Center for Medical Devices of the State Food and Drug Administration. They also held a symposium to gain an in-depth understanding of the transformation of innovative achievements in the pharmaceutical industry and drug supervision in the Greater Bay Area. Yang Sheng emphasized the need to strengthen talent training, thoroughly implement the "three unifications" work goals, and create a high-quality professional review and inspection team. It is necessary to focus on key varieties, continue to improve service methods and methods, and effectively meet the needs of industry and product innovation and development.
Comments